Earlier this year we highlighted
the growth of the Chemical Probes Portal, a free website that profiles more
than 500 small molecules targeting more than 400 proteins. Each chemical probe
is evaluated by experts based on published literature and then scored for use in
cells or in vivo. More than 300 chemical probes have received three or four
stars and are thus recommended. But even a good probe can be misused, and this is
the subject of a recent (open-access) Nat. Comm. paper from Adam McCluskey,
Lenka Munoz, and colleagues at the University of Sydney and the University of
Newcastle. (The paper has also been discussed by Paul Workman and Derek Lowe.)
The researchers chose eight
probes targeting histone methyltransferases, a histone demethylase, a histone
acetyltransferase, and several kinases. All but one of these probes had first
been disclosed before 2015. A literature search revealed 662 papers that used
these probes in cellular studies, ranging from 21 to 134 publications per probe.
Centuries ago the alchemist Paracelsus
noted that everything is poisonous at high enough doses, and indeed even the
best probes might hit dozens or hundreds of protein targets. For this reason the
Chemical Probes Portal recommends maximum concentrations for cellular assays. The
researchers examined whether papers exceeded these concentrations. The overall
results were encouraging, with just 22% of papers exceeding recommended limits.
However, there was considerable variation: for one chemical probe, 70% of papers exceeded the limit. (For this particular case, the maximum recommended
cellular concentration was just 250 nM.)
Because chemical probes can have off-target
activity even at recommended concentrations, best practices are to include a
related but inactive control compound plus a second chemically
differentiated probe. All but one of the eight probes chosen for analysis had
orthogonal probes available, and five had inactive controls. So how frequently
were these used? Unfortunately, 58% of papers did not use an orthogonal probe,
and a whopping 92% of papers did not use available inactive control compounds.
In fact, just 4% of the papers “used chemical probes within the recommended
concentration range and included inactive compounds as well as orthogonal
chemical probes.”
A wider analysis of nearly 15,000
papers that cited the 662 publications produced similar results, with 17%
exceeding recommended concentrations, 59% not using differentiated chemical probes,
and 83% not using inactive controls.
The researchers propose a “'rule
of two': At least two chemical probes (either orthogonal target-engaging
probes, and/or a pair of a chemical probe and matched target-inactive compound)
to be employed at recommended concentrations in every study.” To encourage best
practices, the paper provides a simple “Researchers’ Flowchart” to help
investigators select probes and controls. And because science is
self-regulated, they provide a five-item “Reviewers’ Checklist.” The paper
also includes a nice list of links to other resources, including webinars and slide
decks.
Overall I think following these
guidelines would be beneficial, and the Reviewers’ Checklist in particular could
be usefully incorporated into journal publication requirements.
Of course, the vast majority of protein
targets don’t have even a single good chemical probe, let alone two or more. Which
means that there are plenty of opportunities to identify new probes and make
better use of those that already exist.
Hi Dan, the article by Lenka Munoz and colleagues states “Analysed publications were considered complying or partially complying if they employed a given chemical probe within the recommended in-cell concentration range, used matched target-inactive control compound (where available), and at least one orthogonal inhibitor (where available) (Fig. 2)”. My understanding is that in-cell concentration is not typically measured in studies using (or even validating) chemical probes although I’ll be happy to be proven wrong on this point.
ReplyDeleteHi Pete,
ReplyDeleteThe previous sentence states that "full-text contents across these 662 publications were analysed for chemical probes’ concentration in cell-based assays," so my assumption is that they are referring to the concentration of compound in cell assays rather than the concentration of compound in cells, which is difficult to measure.
The authors do make frequent use of the term “in-cell concentration” (I counted 19 instances of the term in the text of the article) and I would argue that they do need to say exactly what they mean by the term. Intracellular concentration can be measured (this is fiddly) but one can also assume that the intracellular free concentration and extracellular free concentration are equal (this assumption breaks down for poorly permeable compounds, when active transport is significant and for ionizable compounds if the target is in a compartment where pH differs from neutral pH).
ReplyDeleteI corresponded with Prof Lenka Munoz about use of the term 'in-cell concentration'. She tells me that, as assumed by Dan, this refers to the concentration used in vitro cell-based experiments, i.e. the concentration to treat the cells, the concentration in the media. Not the concentration in cells, which is hard to measure.
ReplyDeleteThe Sterling et al article in Nature Comms is very important study showing the extent to which biologists fail to comply with best practice in the use of chemical probes. I wrote about this on 30th June 2023 on my Drug Discoverer blog hosted on the ICR website.
Here is the link to my blog https://www.icr.ac.uk/blogs/the-drug-discoverer/page-details/as-research-tools-improve-our-use-of-them-must-evolve-too-we-re-here-to-help
ReplyDelete